Ingersoll Rand Inc (IR) Stock News

Rosen Law Firm is soliciting investors who purchased securities of Ardelyx, Inc., Anavex Life Sciences Corp., and AST SpaceMobile, Inc. during specified periods to join class action lawsuits. The firm alleges these companies made materially false statements regarding commercial performance and growth prospects. Investors have until November 16, 2026 to serve as lead plaintiffs.

Rosen Law Firm is reminding investors who purchased Baidu securities between November 18, 2025 and August 17, 2026 of the November 13, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Baidu made false statements about its AI business's ability to offset declines in its legacy online marketing business, resulting in materially misleading statements about the company's prospects.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, inadequate care, Medicare/Medicaid fraud, falsification of staffing records, and illegal licensing schemes. The firm is seeking lead plaintiffs with a deadline of December 7, 2026.

Rosen Law Firm is urging investors who purchased Fluence Energy (FLNC) securities between November 24, 2025 and September 16, 2026 to join a class action lawsuit. The lawsuit alleges that Fluence Energy made materially false statements regarding its ability to deliver backlog and meet fiscal 2026 revenue guidance, citing incomplete manufacturing facilities and unresolved production problems that undermined the company's positive business projections.

Rosen Law Firm has filed a securities class action lawsuit against Tigo Energy, Inc. (NASDAQ: TYGO) on behalf of investors who purchased securities between February 24, 2026 and August 4, 2026. The lawsuit alleges that Tigo made materially false and misleading statements regarding revenue projections based on an EG4 partnership that would not generate material revenue until Q4 2026 at the earliest, lacking a reasonable basis for the projections. The lead plaintiff deadline is November 23, 2026.

Rosen Law Firm has filed a class action lawsuit against Netcapital Inc. on behalf of investors who purchased securities between December 15, 2021 and September 3, 2026. The lawsuit alleges that Netcapital improperly recognized revenues from sham consulting agreements, backdated and forged contracts, undisclosed related-party transactions, and made false Sarbanes-Oxley certifications. Investors must move the court by December 7, 2026 to serve as lead plaintiff.

Rosen Law Firm is encouraging investors who purchased Hims & Hers Health, Inc. securities between August 4, 2025 and July 29, 2026 to join a class action lawsuit. The lawsuit alleges that Hims made materially false and misleading statements regarding data privacy practices, prescription charging procedures, and regulatory compliance, which subjected the company to potential fees and penalties.

Rosen Law Firm is urging investors who purchased Beta Bionics common stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, which the FDA found was malfunctioning and dosing patients with dangerously high insulin levels. The firm claims thousands of complaints were filed with the FDA, contradicting defendants' assertions that issues were benign. The lead plaintiff deadline is November 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Alphabet Inc. on behalf of investors who purchased securities between May 19, 2026 and July 16, 2026. The lawsuit alleges that Alphabet made materially false and misleading statements regarding the Gemini 3.5 Pro, claiming it delivered disappointing training results and would face significant launch delays. Investors who purchased during this period may be eligible for compensation. The deadline to serve as lead plaintiff is December 1, 2026.

Rosen Law Firm has filed a class action lawsuit against Webull Corporation on behalf of investors who purchased securities between April 26, 2025 and October 6, 2026. The lawsuit alleges that Webull made false and misleading statements about its operations, claiming its principal business was U.S.-based when in fact its software development, data pipelines, and core engineering heavily depended on PRC-based personnel and infrastructure subject to Chinese law. Investors who purchased during the class period may be entitled to compensation. The deadline to serve as lead plaintiff is December 7, 2026.

Mirion Technologies (MIR) closed at $16.22 with a mean analyst price target of $24, suggesting 48% upside potential. The stock has a Zacks Rank #2 (Buy) rating and shows positive earnings estimate revisions over the last 30 days. However, the article cautions that price targets alone should not be the sole basis for investment decisions, as analysts often set overly optimistic targets due to business incentives.

Quince Therapeutics has rebranded to IRulya Therapeutics and will trade on Nasdaq under ticker 'IRLA' starting October 12, 2026. The company is focused on advancing LAM-001, an inhaled rapamycin formulation for pulmonary diseases including PH-ILD, BOS, and SAPH. New leadership has been appointed including CEO Brigette Roberts, M.D., and the company has a cash balance of $116 million expected to fund operations through end of 2028.

Rosen Law Firm has filed class action lawsuits against Netcapital Inc., The Ensign Group, Inc., and Duolingo, Inc. on behalf of investors who purchased securities during specified periods. The Netcapital lawsuit alleges improper revenue recognition from sham consulting agreements, backdated contracts, and false Sarbanes-Oxley certifications. Investors have until December 7, 2026 to move the court if they wish to serve as lead plaintiff.

Rosen Law Firm has filed a class action lawsuit on behalf of Fluence Energy, Inc. (NASDAQ: FLNC) investors who purchased securities between November 24, 2025 and September 16, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the company's ability to deliver its backlog and meet fiscal 2026 revenue guidance, citing incomplete manufacturing facilities and unresolved production problems. Investors who purchased during the class period may be entitled to compensation. The deadline to serve as lead plaintiff is November 30, 2026.

Rosen Law Firm has filed securities class action lawsuits against Tigo Energy, FuelCell Energy, and Fluence Energy, alleging that defendants made materially false and misleading statements regarding business projections and financial prospects. Investors who purchased securities during specified class periods are encouraged to seek counsel before the November 23, 2026 lead plaintiff deadline.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Celsius Holdings, Inc. and other companies. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased securities during the specified class periods may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Better Home & Finance Holding Company (BETR) on behalf of investors who purchased securities between March 13, 2026 and May 7, 2026. The lawsuit alleges that defendants made false and misleading statements regarding the company's conversion funnel and $1 billion monthly funded volume target, which were slowing due to macro factors. Investors who wish to serve as lead plaintiff must file by November 20, 2026.

Virtu Financial (VIRT) has been upgraded to Zacks Rank #2 (Buy) due to rising earnings estimates over the past three months, with consensus estimates increasing 14.9%. The upgrade reflects an improving business outlook and positions the stock in the top 20% of Zacks-covered stocks, suggesting potential near-term price appreciation.

Pomerantz LLP is investigating potential securities fraud claims against AirSculpt Technologies following a significant stock price decline of 45.11% on August 10, 2026, after the company reported lower-than-expected quarterly revenue of $42.9 million, down from $44.0 million year-over-year.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Papa John's International (PZZA) on behalf of investors who purchased stock between August 7, 2025 and August 5, 2026. The lawsuit alleges that Papa John's made materially false and misleading statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, requiring a shift toward increased promotional efforts.

Rosen Law Firm is reminding investors who purchased Tigo Energy securities between February 24, 2026 and August 4, 2026 of the November 23, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Tigo made materially false and misleading statements regarding revenue projections based on an EG4 partnership that would not generate material revenue until Q4 2026 at the earliest, lacking a reasonable basis for the projections.

Rosen Law Firm has filed securities class action lawsuits against Taboola.com Ltd., The Simply Good Foods Company, and Tigo Energy, Inc. The firm is seeking lead plaintiffs and encouraging investors who purchased securities during specified class periods to join the litigation. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) following an FDA Complete Response Letter on February 13, 2026, regarding its bitopertin program. The FDA stated it could not approve the new drug application due to uncertainties requiring additional evidence. Disc Medicine's stock price fell 22% on the news. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm has filed class action lawsuits against Qfin Holdings, Inc. and Anavex Life Sciences Corp. on behalf of investors who purchased securities during specified periods. The Qfin lawsuit alleges defendants made false statements about business resilience and downplayed regulatory impacts. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.

Sirius XM (SIRI) rose 2.29% to $26.31, outperforming the S&P 500's 0.66% gain. However, the company faces headwinds with expected EPS down 9.52% year-over-year and consensus estimates revised 0.55% lower over the past month. The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 8.57, trading at a discount to its industry average.

Vallourec announces the appointment of Isabelle Quéméneur as Director of Digital & IT Systems, effective October 5, 2026. She joins the Executive Committee and brings extensive experience from her previous role as CTO at Danone, along with a background in technology leadership at major international companies including Société Générale, AXA, and Sanofi.

Rosen Law Firm is soliciting investors who purchased AppLovin Corporation (NASDAQ: APP) securities between February 12, 2026 and August 5, 2026 to join a class action lawsuit. The lawsuit alleges that AppLovin made false statements regarding its generative AI video creative feature, overstated AI model improvements, and misrepresented the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

A securities class action lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging the company made materially false and misleading statements about its iLet Bionic Pancreas insulin pump. The FDA reportedly raised serious safety concerns including device malfunctions and dangerously high insulin dosing causing hypoglycemic events. The lawsuit claims Beta Bionics failed to implement meaningful corrective actions despite thousands of complaints. Investors who purchased stock between July 30, 2025 and February 24, 2026 may be eligible for compensation, with a November 3, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm reminds investors in Alarum Technologies Ltd. (NASDAQ: ALAR) who purchased securities between March 20, 2025 and July 2, 2026 of the October 5, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Alarum Technologies and its subsidiary NetNut engaged in illegal activity by linking customer home internet devices to unauthorized networks without consent, enabling cybercriminals to conceal their locations. Defendants allegedly made false and misleading statements about the company's business and prospects, causing investor damages.

Rosen Law Firm is reminding investors in Alibaba Group Holding Limited, Flotek Industries, Inc., and The Simply Good Foods Company of upcoming lead plaintiff deadlines in securities class actions. The Alibaba lawsuit alleges the company made false statements regarding military affiliations and AI model distillation attacks. Investors with losses exceeding $100,000 are encouraged to seek counsel before the October 5, 2026 deadline for Alibaba.